For example, the activation of HBsAg-specific T cells by engineered anti-PDL1-IFNalpha heterodimers targeting the liver resulted in the disruption of immune tolerance in hepatitis B mice [30]. This evidence concerns the gene IFNA1 and Hepatitis.